Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Early effects of renal replacement therapy on cardiovascular comorbidity in children with end-stage kidney disease: findings from the 4C-T Study.

Schmidt BMW, Sugianto RI, Thurn D, Azukaitis K, Bayazit AK, Canpolat N, Eroglu AG, Caliskan S, Doyon A, Duzova A, Karagoz T, Anarat A, Deveci M, Mir S, Ranchin B, Shroff R, Baskin E, Litwin M, Özcakar ZB, Büscher R, Soylemezoglu O, Dusek J, Kemper M, Matteucci MC, Habbig S, Laube G, Wühl E, Querfeld U, Sander A, Schaefer F, Melk A; 4C Study Consortium.

Transplantation. 2017 Sep 18. doi: 10.1097/TP.0000000000001948. [Epub ahead of print]

PMID:
28926375
2.

Cholestasis After Pediatric Liver Transplantation-Recurrence of a Progressive Familial Intrahepatic Cholestasis Phenotype as a Rare Differential Diagnosis: A Case Report.

Prusinskas B, Kathemann S, Pilic D, Hegen B, Küster P, Keitel V, Häussinger D, Büscher R, Baba HA, Hoyer PF, Lainka E.

Transplant Proc. 2017 Sep;49(7):1628-1633. doi: 10.1016/j.transproceed.2017.06.011.

PMID:
28838453
3.

Factors associated with cardiovascular target organ damage in children after renal transplantation.

Borchert-Mörlins B, Thurn D, Schmidt BMW, Büscher AK, Oh J, Kier T, Bauer E, Baig S, Kanzelmeyer N, Kemper MJ, Büscher R, Melk A.

Pediatr Nephrol. 2017 Aug 13. doi: 10.1007/s00467-017-3771-8. [Epub ahead of print]

PMID:
28804814
4.

Glomerular and Tubular Renal Function after Repeated Once-Daily Tobramycin Courses in Cystic Fibrosis Patients.

Stehling F, Büscher R, Grosse-Onnebrink J, Hoyer PF, Mellies U.

Pulm Med. 2017;2017:2602653. doi: 10.1155/2017/2602653. Epub 2017 Jan 4.

5.

Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders.

Wehling C, Amon O, Bommer M, Hoppe B, Kentouche K, Schalk G, Weimer R, Wiesener M, Hohenstein B, Tönshoff B, Büscher R, Fehrenbach H, Gök ÖN, Kirschfink M.

Clin Exp Immunol. 2017 Feb;187(2):304-315. doi: 10.1111/cei.12890. Epub 2016 Nov 25.

PMID:
27784126
6.

FAT1 mutations cause a glomerulotubular nephropathy.

Gee HY, Sadowski CE, Aggarwal PK, Porath JD, Yakulov TA, Schueler M, Lovric S, Ashraf S, Braun DA, Halbritter J, Fang H, Airik R, Vega-Warner V, Cho KJ, Chan TA, Morris LG, ffrench-Constant C, Allen N, McNeill H, Büscher R, Kyrieleis H, Wallot M, Gaspert A, Kistler T, Milford DV, Saleem MA, Keng WT, Alexander SI, Valentini RP, Licht C, Teh JC, Bogdanovic R, Koziell A, Bierzynska A, Soliman NA, Otto EA, Lifton RP, Holzman LB, Sibinga NE, Walz G, Tufro A, Hildebrandt F.

Nat Commun. 2016 Feb 24;7:10822. doi: 10.1038/ncomms10822.

7.

Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome.

Braun DA, Sadowski CE, Kohl S, Lovric S, Astrinidis SA, Pabst WL, Gee HY, Ashraf S, Lawson JA, Shril S, Airik M, Tan W, Schapiro D, Rao J, Choi WI, Hermle T, Kemper MJ, Pohl M, Ozaltin F, Konrad M, Bogdanovic R, Büscher R, Helmchen U, Serdaroglu E, Lifton RP, Antonin W, Hildebrandt F.

Nat Genet. 2016 Apr;48(4):457-65. doi: 10.1038/ng.3512. Epub 2016 Feb 15.

8.

Combined liver and kidney transplantation and kidney after liver transplantation in children: Indication, postoperative outcome, and long-term results.

Büscher R, Büscher AK, Cetiner M, Treckmann JW, Paul A, Vester U, Hoyer PF.

Pediatr Transplant. 2015 Dec;19(8):858-65. doi: 10.1111/petr.12595. Epub 2015 Sep 5.

PMID:
26341656
9.

Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis.

Ha IS, Yap HK, Munarriz RL, Zambrano PH, Flynn JT, Bilge I, Szczepanska M, Lai WM, Antonio ZL, Gulati A, Hooman N, van Hoeck K, Higuita LM, Verrina E, Klaus G, Fischbach M, Riyami MA, Sahpazova E, Sander A, Warady BA, Schaefer F; International Pediatric Peritoneal Dialysis Network Registry.

Kidney Int. 2015 Sep;88(3):605-13. doi: 10.1038/ki.2015.108. Epub 2015 Apr 15.

10.

Automated Greulich-Pyle bone age determination in children with chronic kidney disease.

Nüsken E, Imschinetzki D, Nüsken KD, Körber F, Mentzel HJ, Peitz J, Bald M, Büscher R, John U, Klaus G, Konrad M, Pape L, Tönshoff B, Martin D, Weber L, Dötsch J.

Pediatr Nephrol. 2015 Jul;30(7):1173-9. doi: 10.1007/s00467-015-3042-5. Epub 2015 Mar 19.

PMID:
25787071
11.

Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease.

Doyon A, Fischer DC, Bayazit AK, Canpolat N, Duzova A, Sözeri B, Bacchetta J, Balat A, Büscher A, Candan C, Cakar N, Donmez O, Dusek J, Heckel M, Klaus G, Mir S, Özcelik G, Sever L, Shroff R, Vidal E, Wühl E, Gondan M, Melk A, Querfeld U, Haffner D, Schaefer F; 4C Study Consortium.

PLoS One. 2015 Feb 6;10(2):e0113482. doi: 10.1371/journal.pone.0113482. eCollection 2015.

12.

A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome.

Sadowski CE, Lovric S, Ashraf S, Pabst WL, Gee HY, Kohl S, Engelmann S, Vega-Warner V, Fang H, Halbritter J, Somers MJ, Tan W, Shril S, Fessi I, Lifton RP, Bockenhauer D, El-Desoky S, Kari JA, Zenker M, Kemper MJ, Mueller D, Fathy HM, Soliman NA; SRNS Study Group, Hildebrandt F.

J Am Soc Nephrol. 2015 Jun;26(6):1279-89. doi: 10.1681/ASN.2014050489. Epub 2014 Oct 27.

13.

Urinary tract effects of HPSE2 mutations.

Stuart HM, Roberts NA, Hilton EN, McKenzie EA, Daly SB, Hadfield KD, Rahal JS, Gardiner NJ, Tanley SW, Lewis MA, Sites E, Angle B, Alves C, Lourenço T, Rodrigues M, Calado A, Amado M, Guerreiro N, Serras I, Beetz C, Varga RE, Silay MS, Darlow JM, Dobson MG, Barton DE, Hunziker M, Puri P, Feather SA, Goodship JA, Goodship TH, Lambert HJ, Cordell HJ; UK VUR Study Group, Saggar A, Kinali M; 4C Study Group, Lorenz C, Moeller K, Schaefer F, Bayazit AK, Weber S, Newman WG, Woolf AS.

J Am Soc Nephrol. 2015 Apr;26(4):797-804. doi: 10.1681/ASN.2013090961. Epub 2014 Aug 21.

14.

[Childhood ureteropelvic junction obstruction in a regional treatment center: spectrum and therapy].

Eisenhardt A, Rübben H, Rübben I, Dakkak D, Hoyer PF, Büscher R.

Urologe A. 2013 Dec;52(12):1698-704. doi: 10.1007/s00120-013-3346-7. German.

PMID:
24258353
15.

Clinical manifestations of autosomal recessive polycystic kidney disease (ARPKD): kidney-related and non-kidney-related phenotypes.

Büscher R, Büscher AK, Weber S, Mohr J, Hegen B, Vester U, Hoyer PF.

Pediatr Nephrol. 2014 Oct;29(10):1915-25. doi: 10.1007/s00467-013-2634-1. Epub 2013 Oct 10. Review.

PMID:
24114580
16.

Evaluation of the peer teaching program at the University Children´s Hospital Essen - a single center experience.

Büscher R, Weber D, Büscher A, Hölscher M, Pohlhuis S, Groes B, Hoyer PF.

GMS Z Med Ausbild. 2013 May 15;30(2):Doc25. doi: 10.3205/zma000868. Print 2013.

17.

Management of anemia in children receiving chronic peritoneal dialysis.

Borzych-Duzalka D, Bilginer Y, Ha IS, Bak M, Rees L, Cano F, Munarriz RL, Chua A, Pesle S, Emre S, Urzykowska A, Quiroz L, Ruscasso JD, White C, Pape L, Ramela V, Printza N, Vogel A, Kuzmanovska D, Simkova E, Müller-Wiefel DE, Sander A, Warady BA, Schaefer F; International Pediatric Peritoneal Dialysis Network (IPPN) Registry.

J Am Soc Nephrol. 2013 Mar;24(4):665-76. doi: 10.1681/ASN.2012050433. Epub 2013 Mar 7.

18.

COL4A5-associated X-linked Alport syndrome in a female patient with early inner ear deafness due to a mutation in MYH9.

Strasser K, Hoefele J, Bergmann C, Büscher AK, Büscher R, Hoyer PF, Weber S.

Nephrol Dial Transplant. 2012 Nov;27(11):4236-40. doi: 10.1093/ndt/gfs468.

PMID:
23144074
19.

Comorbidities in chronic pediatric peritoneal dialysis patients: a report of the International Pediatric Peritoneal Dialysis Network.

Neu AM, Sander A, Borzych-Duzalka D, Watson AR, Vallés PG, Ha IS, Patel H, Askenazi D, Balasz-Chmielewska I, Lauronen J, Groothoff JW, Feber J, Schaefer F, Warady BA; IPPN investigators.

Perit Dial Int. 2012 Jul-Aug;32(4):410-8.

20.

Impact of global economic disparities on practices and outcomes of chronic peritoneal dialysis in children: insights from the International Pediatric Peritoneal Dialysis Network Registry.

Schaefer F, Borzych-Duzalka D, Azocar M, Munarriz RL, Sever L, Aksu N, Barbosa LS, Galan YS, Xu H, Coccia PA, Szabo A, Wong W, Salim R, Vidal E, Pottoore S, Warady BA; IPPN investigators.

Perit Dial Int. 2012 Jul-Aug;32(4):399-409.

Supplemental Content

Loading ...
Support Center